Clinical Trial Update: Reparixin in Pancreatic Islet Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial of Reparixin in pancreatic islet transplantation for type 1 diabetes completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Reparixin (reparixin)

Snippet

Sponsor: Dompé Farmaceutici S.p.A | Conditions: Pancreatic Islet Transplantation in Type 1 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2021-03-11